Annual report pursuant to Section 13 and 15(d)

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

v3.20.1
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Ordinary Shares
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Retained earnings (Accumulated Deficit)
IPO
Private Placement
Total
Balance at beginning of period at Nov. 05, 2018 $ 0     $ 0 $ 0     $ 0
Balance at beginning of period (in shares) at Nov. 05, 2018 0              
Increase (Decrease) in Stockholders' Equity                
Issuance of ordinary shares to Sponsor [1] $ 719     24,281       25,000
Issuance of ordinary shares to Sponsor (in shares) [1] 7,187,500              
Net income (loss)         (2,694)     (2,694)
Balance at end of period at Dec. 31, 2018 $ 719     24,281 (2,694)     22,306
Balance at end of period (in shares) at Dec. 31, 2018 7,187,500              
Increase (Decrease) in Stockholders' Equity                
Sale of units in initial public offerings, gross $ 2,875 $ 287,497,125 $ 7,750,000     $ 287,500,000 $ 7,750,000  
Sale of units in initial public offering, gross (in shares) 28,750,000              
Offering costs       (15,075,329)       (15,075,329)
Ordinary shares subject to possible redemption $ (2,794)     (279,420,936)       (279,423,730)
Ordinary shares subject to possible redemption (in shares) (27,942,373)              
Net income (loss)         4,226,759     4,226,759
Balance at end of period at Dec. 31, 2019 $ 800     $ 775,141 $ 4,224,065     $ 5,000,006
Balance at end of period (in shares) at Dec. 31, 2019 7,995,127              
[1] This number includes up to 937,500 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On April 5, 2019, the underwriters fully exercised their over-allotment option; thus, the 937,500 Founder Shares were no longer subject to forfeiture.